NOVEL INHIBITORS OF MATRIX METALLOPROTEINASES

Compounds of general formula (I), salts or solvates thereof and pharmaceutical compositions containing same: wherein Z is N or CH or the Z(R1) part is replaced with a covalent bond, m and n is 0, 1, 2 or 3; HET is heteroaryl; X is CF3, halogen, CO-heterocyclyl, COOR3 or CONHR3; R1 is H, (CH2)o-aryl,...

Full description

Saved in:
Bibliographic Details
Main Authors KEDVESNÉ KUPAI, Krisztina, HAJDÚ, István, KIS-TAMÁS, Attila, FERDINANDY, Péter, CSONKA, Csaba, GÖRBE, Anikó, KOVÁCS, László, DORMÁN, György, KÓNYA, Dénes, CSEH, Sándor, CSONT, Tamás, Bálint, TAKÁCS, Ferenc Tamás, MEDGYES, Gábor, LÖRINCZ, Zsolt
Format Patent
LanguageEnglish
French
German
Published 22.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of general formula (I), salts or solvates thereof and pharmaceutical compositions containing same: wherein Z is N or CH or the Z(R1) part is replaced with a covalent bond, m and n is 0, 1, 2 or 3; HET is heteroaryl; X is CF3, halogen, CO-heterocyclyl, COOR3 or CONHR3; R1 is H, (CH2)o-aryl, (CH2)p-heteroaryl, (CH2)q-biphenyl; C(O)-R5; S(O)2-R6; R2 is H, aryl, heteroaryl, Y-(CH2)r-aryl, Y-(CH2)s-heteroaryl, where some of the above substituents may be substituted; Y is O or S; with the exclusion of the compound where HET is 1,3-thiazol, X is COOH, R1 is 4-fluorophenyl and R2 is benzyloxy. The invention also relates to the use of a compound of general formula (I), salts or solvates thereof for the use in the prevention or treatment of diseases where the activation of MMPs is involved in the pathomechanism. In this aspect the use of the above excluded compound is also inventive.
Bibliography:Application Number: EP20110811113